In contrast, MYT1 levels were increased in oligodendroglioma and astrocytoma more than in a normal brain, but its expression in both astrocytoma and glioblastoma was significantly lower than in oligodendroglioma. The gene discussed is MYT1; the disease is astrocytoma (excluding glioblastoma).